LENTIVIRAL VECTOR FORMULATIONS
Application
US20260077005A1
Kind: A1
Mar 19, 2026
Inventors
Andrew Kroetsch, Isidro Zarraga
Abstract
Lentiviral vector (LV) formulations, and pharmaceutical compositions comprising such LV formulations, with improved stability and suitable for systemic administration are provided. Methods for treating disorders, especially blood disorders, using systemic administration of LV formulations are also provided.
CPC Classifications
A61K 35/76
A61K 47/26
A61P 7/04
C12N 15/86
Filing Date
2025-07-30
Application No.
19284911